NEWSpublisher 2007 :: AngloChinese Investments
date from:
date to:
search for string:
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » Company watch » TOP 50 Pharmas » Pfizer back to previous page show list
Pfizer »24/06/2008 [Company watch]
NovaMed to distribute six oncology products for Pfizer China

NovaMed Pharmaceuticals announced June 13 that is has entered into an agreement with Pfizer China under which it will act as the exclusive distributor and promoter for six of Pfizer China's anticancer products. NovaMed expects hospital coverage of the products, Adriamycin, Daunoblastina, Leucovorin, Methotrexate, Estracyt and Farlutal, to increase by 30% to 40% in China. NovaMed is a specialty pharmaceutical company providing commercialization and outsourcing services in China for global pharmaceutical and biotech companies. The company seeks to license products that have been launched in international markets but are not yet available in China as well as development stage products. NovaMed has successfully in-licensed programs from several multinational pharmaceutical companies, including recent agreements with Sanofi-Aventis, Baxter International, and Meda AB.


AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.